258 related articles for article (PubMed ID: 21964560)
1. Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.
Andrès E
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):881-8. PubMed ID: 21964560
[TBL] [Abstract][Full Text] [Related]
2. [Cationic anti-microbial peptides: from innate immunity study to drug development].
Andrès E; Dimarcq JL
Rev Med Interne; 2004 Sep; 25(9):629-35. PubMed ID: 15363618
[TBL] [Abstract][Full Text] [Related]
3. [Cationic antimicrobial peptides: from innate immunity study to drug development. Up date].
Andrès E; Dimarcq JL
Med Mal Infect; 2007 Apr; 37(4):194-9. PubMed ID: 17306486
[TBL] [Abstract][Full Text] [Related]
4. Iseganan. IB 367, protegrin IB 367.
Drugs R D; 2002; 3(1):52-5. PubMed ID: 11881532
[No Abstract] [Full Text] [Related]
5. Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides.
Melo MN; Dugourd D; Castanho MA
Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):201-7. PubMed ID: 18221145
[TBL] [Abstract][Full Text] [Related]
6. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.
Hale JD; Hancock RE
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):951-9. PubMed ID: 18039080
[TBL] [Abstract][Full Text] [Related]
7. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
Brogden NK; Brogden KA
Int J Antimicrob Agents; 2011 Sep; 38(3):217-25. PubMed ID: 21733662
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis.
Tan H; Ding X; Meng S; Liu C; Wang H; Xia L; Liu Z; Liang S
Curr Mol Med; 2013 Jul; 13(6):900-10. PubMed ID: 23638903
[TBL] [Abstract][Full Text] [Related]
9. Lead optimization of antifungal peptides with 3D NMR structures analysis.
Landon C; Barbault F; Legrain M; Menin L; Guenneugues M; Schott V; Vovelle F; Dimarcq JL
Protein Sci; 2004 Mar; 13(3):703-13. PubMed ID: 14978308
[TBL] [Abstract][Full Text] [Related]
10. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.
Mookherjee N; Hancock RE
Cell Mol Life Sci; 2007 Apr; 64(7-8):922-33. PubMed ID: 17310278
[TBL] [Abstract][Full Text] [Related]
11. Design, recombinant expression, and antibacterial activity of a novel hybrid magainin-thanatin antimicrobial peptide.
Tian L; Zhang D; Su P; Wei Y; Wang Z; Wang PX; Dai CJ; Gong GL
Prep Biochem Biotechnol; 2019; 49(5):427-434. PubMed ID: 30861356
[TBL] [Abstract][Full Text] [Related]
12. Role of lipids in the interaction of antimicrobial peptides with membranes.
Teixeira V; Feio MJ; Bastos M
Prog Lipid Res; 2012 Apr; 51(2):149-77. PubMed ID: 22245454
[TBL] [Abstract][Full Text] [Related]
13. Defensin-based anti-infective strategies.
Wilmes M; Sahl HG
Int J Med Microbiol; 2014 Jan; 304(1):93-9. PubMed ID: 24119539
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.
Zaiou M
J Mol Med (Berl); 2007 Apr; 85(4):317-29. PubMed ID: 17216206
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial peptides: premises and promises.
Reddy KV; Yedery RD; Aranha C
Int J Antimicrob Agents; 2004 Dec; 24(6):536-47. PubMed ID: 15555874
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity. Ancient system gets new respect.
Gura T
Science; 2001 Mar; 291(5511):2068-71. PubMed ID: 11256394
[No Abstract] [Full Text] [Related]
17. Antimicrobial peptides: potential use in skin infections.
Ulvatne H
Am J Clin Dermatol; 2003; 4(9):591-5. PubMed ID: 12926977
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial peptides: Possible anti-infective agents.
Lakshmaiah Narayana J; Chen JY
Peptides; 2015 Oct; 72():88-94. PubMed ID: 26048089
[TBL] [Abstract][Full Text] [Related]
19. New horizons for host defense peptides and lantibiotics.
Dawson MJ; Scott RW
Curr Opin Pharmacol; 2012 Oct; 12(5):545-50. PubMed ID: 22776251
[TBL] [Abstract][Full Text] [Related]
20. An overview of antimicrobial peptides and the latest advances in their development.
Sierra JM; Fusté E; Rabanal F; Vinuesa T; Viñas M
Expert Opin Biol Ther; 2017 Jun; 17(6):663-676. PubMed ID: 28368216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
